Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Trading Statement

4 Dec 2018 07:00

RNS Number : 2986J
Quartix Holdings PLC
04 December 2018
 

Quartix Holdings plc

("Quartix" or the "Company")

 

Trading Statement

 

Quartix Holdings plc, one of Europe's leading suppliers of subscription-based vehicle tracking systems, software and services, is pleased to provide an update on trading for the 10-month period to 31 October 2018.

 

The Board believes that profit (adjusted EBITDA) is likely to exceed market expectations* for the year to 31 December 2018 by between 10 and 15 per cent. This is largely as a result of the Group's adoption of IFRS15 (Revenue from Contracts with Customers), which has increased profit and revenue in 2018 as noted in the trading statement on 2 July 2018. The estimate is dependent on the trading results for November and December 2018. Revenue and free cashflow are expected to be slightly ahead of market expectations*.

 

The Company has continued to make strong progress in its core fleet business in the USA and France and is pleased to report that, having noted in the interim results statement on 25 July 2018 that growth in the UK subscription base had slowed in relation to the equivalent period for 2017, the changes made since July are beginning to take effect.

 

Management expectations for 2019 remain unchanged and the Company expects to provide a post year-end trading update in mid-January 2019.

 

* The Board believes that consensus market expectations for 2018, prior to this announcement, were as follows: revenue: £24.6m; adjusted EBITDA £7.5m; free cash flow: £5.4m.

 

 

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

 

For further information, please contact:

Quartix (www.quartix.net)

Andrew Walters, Chief Executive

Daniel Mendis, Chief Financial Officer

01686 806 663

 

finnCap (Nominated Adviser and Broker)

Matt Goode /Scott Mathieson (Corporate Finance)

Alice Lane (Corporate Broking)

 

 

020 7220 0500

Cantor Fitzgerald (Joint Broker)

Marc Milmo

Catherine Leftley

020 7894 7000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKMMGZNFGGRZM
Date   Source Headline
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH
3rd Aug 20233:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.